COMPASS Pathways plc

NASDAQ:CMPS

Medical - Care Facilities

Healthcare
$8.12 +0.16%

+$0.02 today

Market cap
$1.15B
Beta
2.51
P/E (TTM)
-7.4
EPS (TTM)
-$1.63
52W Low $2.25High $14.76

Volume 2.35M

Average 4.09M

CMPS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

COMPASS Pathways plcNASDAQ: CMPS

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 110.06M shares rose 23.4% year over year, behind the +33.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 17.5% from the prior quarter. Over 3 fiscal years it compounded at +30.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +23.4% toward the trailing-twelve-month pace of +33.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
110.06M+17.5% QoQ
Last fiscal yearDec 2025
93.5M+38.6% YoY
LTMMar 2026
98.1M+33.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.4%——
1 year+38.6%——
3-year CAGR+30.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
93.5M USD
Year-over-year change
+38.6%
4-year CAGR
+23.7%

Weighted Avg Shares vs competitors

How CMPS compares with its peers on the latest reported figures

  • CMPS's LTM Mar 2026 weighted avg shares of 98.1M shares is the 4th highest of the 11 companies compared; the peer median is 50.49M shares.
  • Its year-over-year change of +33.3% is the 3rd highest of 10, against a peer median of +15.9%.
  • Over three fiscal years its annual growth of +30.1% compares with a peer median of +14.2%.
CMPS Competitors Peer median
Weighted Avg Shares for CMPS and competitors
Company Period LTM YoY 3-year CAGR
DNLIDenali Therapeutics Inc.LTM Jun 2026180.46M +5.8%+11.8%
ACADACADIA Pharmaceuticals Inc.LTM Sep 2026171M +2.1%+1.6%
DFTXDefinium Therapeutics, Inc.LTM Sep 2026111.19M +30.7%+42.5%
CMPSCOMPASS Pathways plcLTM Mar 202698.1M +33.3%+30.1%
GHRSGH Research PLCLTM Mar 202662.03M +15.9%+5.5%
HRMYHarmony Biosciences Holdings, Inc.LTM Jun 202657.95M +1.3%-1.0%
MPLTMapLight Therapeutics, Inc.LTM Mar 202643.04M +3.9%+2.0%
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 202641.9M +115.2%+32.7%
PRAXPraxis Precision Medicines, Inc.LTM Sep 202627.42M +29.8%+94.2%
NERVMinerva Neurosciences, Inc.LTM Jun 202627.3M +260.6%+16.6%
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 202619.77M —+92.6%
Peer median (excluding CMPS) 50.49M+15.9%+14.2%

Competitors are the stored peer set for CMPS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development44.03M65.05M87.52M119.04M118.44M
Selling, General & Admin39.19M45.35M49.4M59.17M60.6M
Operating Expenses83.22M110.4M136.92M178.21M179.04M
Depreciation & Amortization175K330K242K233K216K
EBITDA(71.37M)(90.77M)(115.24M)(148.82M)(285.6M)
EBITDA Margin—————
Operating Income(83.22M)(110.4M)(136.92M)(178.21M)(179.04M)
Operating Margin—————
Interest Income004.62M8.27M7.18M
Interest Expense002.2M4.48M4.52M
Other Income / Expenses11.68M19.31M19.24M24.68M(111.3M)
Income Before Tax(71.54M)(91.1M)(117.68M)(153.53M)(290.34M)
Pre-Tax Margin—————
Income Tax Expense199K408K780K1.59M(2.47M)
Net Income(71.74M)(91.51M)(118.46M)(155.12M)(287.86M)
Net Margin—————
EPS (Basic)(1.79)(2.16)(2.32)(2.30)(3.08)
EPS (Diluted)(1.79)(2.16)(2.32)(2.30)(3.08)
Weighted Avg Shares40M42.44M51.03M67.48M93.5M
Weighted Avg Shares (Diluted)40M42.44M51.03M67.48M93.5M

COMPASS Pathways plc

NASDAQ:CMPS

Intrinsic Alpha fair value

Locked

Current Price

$8.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.